• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GABA 系统,一种针对认知障碍的药物治疗的新靶点——与神经活性甾体有关。

The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroids.

机构信息

Department of Clinical Sciences, University of Umeå, Umeå, Sweden.

Umecrine Cognition AB, Solna, Sweden.

出版信息

J Intern Med. 2023 Sep;294(3):281-294. doi: 10.1111/joim.13705. Epub 2023 Jul 30.

DOI:10.1111/joim.13705
PMID:37518841
Abstract

The prevalence of cognitive dysfunction, dementia, and neurodegenerative disorders such as Alzheimer's disease (AD) is increasing in parallel with an aging population. Distinct types of chronic stress are thought to be instrumental in the development of cognitive impairment in central nervous system (CNS) disorders where cognitive impairment is a major unmet medical need. Increased GABAergic tone is a mediator of stress effects but is also a result of other factors in CNS disorders. Positive GABA-A receptor modulating stress and sex steroids (steroid-PAMs) such as allopregnanolone (ALLO) and medroxyprogesterone acetate can provoke impaired cognition. As such, ALLO impairs memory and learning in both animals and humans. In transgenic AD animal studies, continuous exposure to ALLO at physiological levels impairs cognition and increases degenerative AD pathology, whereas intermittent ALLO injections enhance cognition, indicating pleiotropic functions of ALLO. We have shown that GABA-A receptor modulating steroid antagonists (GAMSAs) can block the acute negative cognitive impairment of ALLO on memory in animal studies and in patients with cognitive impairment due to hepatic encephalopathy. Here we describe disorders affected by steroid-PAMs and opportunities to treat these adverse effects of steroid-PAMs with novel GAMSAs.

摘要

认知功能障碍、痴呆和神经退行性疾病(如阿尔茨海默病[AD])的患病率随着人口老龄化而同步增加。人们认为,中枢神经系统(CNS)疾病中不同类型的慢性应激是导致认知障碍的重要因素,而认知障碍是一种未满足的主要医疗需求。GABA 能神经传递亢进是应激效应的中介,但也是 CNS 疾病中其他因素的结果。正性 GABA-A 受体调节应激和性激素(类固醇-PAMs),如孕烷醇酮(ALLO)和醋酸甲地孕酮,可引起认知障碍。因此,ALLO 会损害动物和人类的记忆和学习能力。在转基因 AD 动物研究中,生理水平的 ALLO 持续暴露会损害认知功能并增加 AD 退行性病变,而间歇性 ALLO 注射则会增强认知功能,表明 ALLO 具有多效功能。我们已经表明,GABA-A 受体调节类固醇拮抗剂(GAMSAs)可以阻断 ALLO 在动物研究和肝性脑病引起认知障碍患者中的急性负性认知损害。在这里,我们描述了受类固醇-PAMs 影响的疾病,并描述了用新型 GAMSAs 治疗这些类固醇-PAMs 的不良反应的机会。

相似文献

1
The GABA system, a new target for medications against cognitive impairment-Associated with neuroactive steroids.GABA 系统,一种针对认知障碍的药物治疗的新靶点——与神经活性甾体有关。
J Intern Med. 2023 Sep;294(3):281-294. doi: 10.1111/joim.13705. Epub 2023 Jul 30.
2
GABAA receptor modulating steroid antagonists (GAMSA) are functional in vivo.γ-氨基丁酸A型受体调节性类固醇拮抗剂(GAMSA)在体内具有功能活性。
J Steroid Biochem Mol Biol. 2016 Jun;160:98-105. doi: 10.1016/j.jsbmb.2015.10.019. Epub 2015 Oct 30.
3
Positive GABA receptor modulating steroids and their antagonists: Implications for clinical treatments.阳性 GABA 受体调节类固醇及其拮抗剂:对临床治疗的影响。
J Neuroendocrinol. 2022 Feb;34(2):e13013. doi: 10.1111/jne.13013. Epub 2021 Aug 1.
4
Modulation of GABA(A) receptor function by neuroactive steroids: evidence for heterogeneity of steroid sensitivity of recombinant GABA(A) receptor isoforms.神经活性甾体对GABA(A)受体功能的调节:重组GABA(A)受体亚型甾体敏感性异质性的证据。
Can J Physiol Pharmacol. 1998 Sep;76(9):909-20. doi: 10.1139/cjpp-76-9-909.
5
Neurosteroid modulation of allopregnanolone and GABA effect on the GABA-A receptor.神经甾体对别孕烯醇酮及γ-氨基丁酸作用于γ-氨基丁酸A受体的调节
Neuroscience. 2006 Nov 17;143(1):73-81. doi: 10.1016/j.neuroscience.2006.07.031. Epub 2006 Aug 28.
6
GABA-A receptor modulating steroids in acute and chronic stress; relevance for cognition and dementia?急性和慢性应激中γ-氨基丁酸A受体调节性类固醇;与认知和痴呆的相关性?
Neurobiol Stress. 2019 Dec 20;12:100206. doi: 10.1016/j.ynstr.2019.100206. eCollection 2020 May.
7
Neurosteroids in hepatic encephalopathy: Novel insights and new therapeutic opportunities.肝性脑病中的神经甾体:新见解与新治疗机遇
J Steroid Biochem Mol Biol. 2016 Jun;160:94-7. doi: 10.1016/j.jsbmb.2015.11.006. Epub 2015 Nov 14.
8
Neuroactive steroid effects on cognitive functions with a focus on the serotonin and GABA systems.神经活性甾体对认知功能的影响,重点关注5-羟色胺和γ-氨基丁酸系统。
Brain Res Rev. 2006 Aug;51(2):212-39. doi: 10.1016/j.brainresrev.2005.11.001. Epub 2005 Dec 20.
9
Tolerance to allopregnanolone with focus on the GABA-A receptor.对孕烷二醇耐受的研究进展——聚焦于 GABA-A 受体。
Br J Pharmacol. 2011 Jan;162(2):311-27. doi: 10.1111/j.1476-5381.2010.01059.x.
10
The neuroactive steroid allopregnanolone suppresses hypothalamic gonadotropin-releasing hormone release through a mechanism mediated by the gamma-aminobutyric acidA receptor.神经活性甾体别孕烯醇酮通过γ-氨基丁酸A受体介导的机制抑制下丘脑促性腺激素释放激素的释放。
J Endocrinol. 1998 Jul;158(1):121-5. doi: 10.1677/joe.0.1580121.

引用本文的文献

1
Research on the Correlation between BDNF Val76Met Polymorphism and Susceptibility to Changes of Cognitive Function in Rats Induced by Microwave Radiation.脑源性神经营养因子Val76Met多态性与微波辐射诱导大鼠认知功能变化易感性的相关性研究
Neurochem Res. 2025 Jul 19;50(4):238. doi: 10.1007/s11064-025-04480-1.
2
Arhgef7 as a key target for enriched environment rescuing spatial cognitive deficits and anxiety-like behaviors in a mouse model of Alzheimer's disease following early social isolation.在早期社会隔离后的阿尔茨海默病小鼠模型中,Arhgef7作为丰富环境挽救空间认知缺陷和焦虑样行为的关键靶点。
Alzheimers Res Ther. 2025 Jul 1;17(1):143. doi: 10.1186/s13195-025-01797-5.
3
Safety evaluation of medroxyprogesterone acetate: a pharmacovigilance analysis using FDA adverse event reporting system data.
醋酸甲羟孕酮的安全性评估:一项使用美国食品药品监督管理局不良事件报告系统数据的药物警戒分析。
Front Pharmacol. 2024 Dec 11;15:1491032. doi: 10.3389/fphar.2024.1491032. eCollection 2024.
4
Intervention effect of regulating GABA-A receptor activity on the formation of experimental abdominal aortic aneurysm in rats.调节γ-氨基丁酸A受体活性对大鼠实验性腹主动脉瘤形成的干预作用
Sci Rep. 2024 Dec 28;14(1):31388. doi: 10.1038/s41598-024-82913-7.
5
Neurosteroid Levels in GBA Mutated and Non-Mutated Parkinson's Disease: A Possible Factor Influencing Clinical Phenotype?脑源性甾体水平在 GBA 突变和非突变帕金森病中的变化:影响临床表型的可能因素?
Biomolecules. 2024 Aug 17;14(8):1022. doi: 10.3390/biom14081022.